Baxter
BAX
#1126
Rank
A$25.57 B
Marketcap
$50.09
Share price
0.34%
Change (1 day)
-7.69%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of June 2024 : A$20.48 Billion

According to Baxter's latest financial reports the company's total debt is A$20.48 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$21.08 B-16.6%
2022-12-31A$25.27 B0.09%
2021-12-31A$25.25 B185.42%
2020-12-31A$8.84 B3.93%
2019-12-31A$8.51 B72.11%
2018-12-31A$4.94 B9.97%
2017-12-31A$4.49 B16.56%
2016-12-31A$3.85 B-56.79%
2015-12-31A$8.93 B-19.04%
2014-12-31A$11.03 B7.36%
2013-12-31A$10.27 B80.08%
2012-12-31A$5.70 B12.63%
2011-12-31A$5.06 B17.31%
2010-12-31A$4.31 B-6.54%
2009-12-31A$4.62 B-13.2%
2008-12-31A$5.32 B50.68%
2007-12-31A$3.53 B-0.56%
2006-12-31A$3.55 B-22.11%
2005-12-31A$4.56 B-17.79%
2004-12-31A$5.54 B-9.83%
2003-12-31A$6.15 B-25.39%
2002-12-31A$8.24 B56.66%
2001-12-31A$5.26 B24.73%
2000-12-31A$4.22 B-2.88%
1999-12-31A$4.34 B-20.96%
1998-12-31A$5.49 B28.92%
1997-12-31A$4.26 B66.02%
1996-12-31A$2.56 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$7.92 B-61.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.77 B 16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.28 B-15.63%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.66 B 44.82%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.30 B-88.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$54.21 B 164.66%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.33 B-83.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$42.77 B 108.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$2.57 B-87.42%๐Ÿ‡บ๐Ÿ‡ธ USA